SOURCE: SOHM, Inc.

February 04, 2010 16:00 ET

SOHM Inc.: Grass Roots Research, Inc. Initiates Buy Recommendation Coverage With a Long-Term Target Price of $.41 per Share

BUENA PARK, CA--(Marketwire - February 4, 2010) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that Grass Roots Research and Distribution, Inc., a Wall Street leading independent research firm, has initiated unsolicited coverage on SOHM, Inc. with a "BUY" recommendation and a Long-Term Target Price of $.41 per share. SOHM Inc. makes no representation regarding the price target or methodology contained in the report. Grass Roots provides an in-depth analysis, including 5-year financial and valuation projections, on SOHM Inc.'s business and growth drivers. The research report and "Buy" recommendation on SOHM, Inc. can be found at: http://www.grassrootsrd.com/CompanyDetails.aspx?cid=62

About Grass Roots Research and Distribution, Inc. (GRRD) (www.grassrootsrd.com).

GRRD has raised the art of fundamental securities research by forecasting and valuing all of its companies in three cases over a 5-year time period. GRRD's independent third party stock research business selectively initiates Independent Research Analyst Coverage for overlooked public corporations. GRRD identifies and initiates non-traditional company research. GRRD selects micro cap stocks and small cap stocks with management teams focused on shareholder value, sustainable competitive advantage, and companies that demonstrate market leadership in their respective disciplines. GRRD distributes in-depth stock market research reports that highlight the company's market opportunity, technology, management, competition and other key differentiators that may affect their short and long term valuation.

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact